Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 928 (LINC00928) is a member of the lincRNA class, which are autonomously transcribed RNA molecules longer than 200 nucleotides and do not overlap protein-coding regions[1]. LincRNAs, as a family, function in chromatin remodeling, transcriptional and posttranscriptional gene regulation, and fine-tuning gene expression in a tissue-specific manner[1][3]. Some lincRNAs participate in disease and cellular processes, including cancer and development, but no specific function, disease association, or therapeutic relevance is documented for LINC00928 as of the current sources reviewed. Based on available scientific literature and genomic databases, there is currently no evidence that LINC00928 encodes a protein, has been robustly characterized functionally, or is implicated in human disease. There are no reports that LINC00928 is a therapeutic target, druggable entity, or biomarker, and no approved or experimental drugs are documented to interact with it. Ensure not to confuse this target with LINC00948, a lincRNA known to encode a functional micropeptide (myoregulin) important in muscle biology[2]. Because LINC00928 is uncharacterized and has not been linked to therapeutic or disease contexts, it is not currently viewed as a relevant biological target. Steps for curation or annotation should flag "is_incorrect: true" due to lack of direct functional or disease-related evidence, and to avoid misannotation with similar lincRNA names.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 928 (LINC00928).